Waldencast (WALD) Expected to Announce Earnings on Tuesday

Posted by Brenda Bartman on Aug 3rd, 2026

Waldencast (NASDAQ:WALD – Get Free Report) is projected to announce its Q1 2026 results before the market opens on Tuesday, August 4th. Analysts expect Waldencast to announce earnings of ($0.17) per share and revenue of $66.1470 million for the quarter. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, August 13, 2026 at 2:00 AM ET.

Waldencast Stock Performance

Shares of NASDAQ WALD traded down $0.01 during trading on Monday, reaching $1.72. The stock had a trading volume of 32,331 shares, compared to its average volume of 678,723. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.70 and a quick ratio of 0.97. Waldencast has a one year low of $0.72 and a one year high of $3.22. The firm’s 50 day moving average price is $1.66 and its two-hundred day moving average price is $1.50.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. UBS Group AG boosted its stake in shares of Waldencast by 466.2% in the 3rd quarter. UBS Group AG now owns 838,536 shares of the company’s stock valued at $1,660,000 after purchasing an additional 690,441 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Waldencast by 62.2% in the 2nd quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock valued at $1,437,000 after purchasing an additional 224,905 shares during the last quarter. Beartown Capital Management LLC acquired a new stake in Waldencast during the 4th quarter worth $564,000. Rhumbline Advisers boosted its position in shares of Waldencast by 15.2% in the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock worth $185,000 after purchasing an additional 8,151 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Waldencast by 80.3% during the fourth quarter. Goldman Sachs Group Inc. now owns 87,015 shares of the company’s stock worth $164,000 after purchasing an additional 38,749 shares during the period. Institutional investors and hedge funds own 41.97% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on WALD shares. Wall Street Zen raised shares of Waldencast to a “hold” rating in a report on Saturday, May 30th. Weiss Ratings lowered Waldencast from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. Finally, Canaccord Genuity Group increased their price target on Waldencast from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $2.33.

View Our Latest Stock Analysis on WALD

Waldencast Company Profile

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.